LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported net income of $5.9 million in its second quarter.
On a per-share basis, the Los Angeles-based company said it had profit of 12 cents. Earnings, adjusted for stock option expense, were 15 cents per share.
The biopharmaceutical company posted revenue of $52.4 million in the period.
For the current quarter ending in September, Puma Biotech said it expects revenue in the range of $48 million to $51 million.
The company expects full-year revenue in the range of $212 million to $222 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
